Hopp til hovedinnhold

Generalisert angstlidelse (GAD)

Sist oppdatert: Sist revidert:
Sist revidert av:

Definisjon:
Uttalt bekymring for daglige hendelser, problemer eller framtidig ulykke, som ikke er kontrollerbar, og som er forbundet med flere kroppslige og kognitive symptomer og har en varighet > 6 måneder
Forekomst:
Livstidsprevalens er ca 3-6%, med dobbelt så mange kvinner som menn
Symptomer:
Typiske plager er vedvarende og diffus uberettiget bekymring/angst mer eller mindre hele tiden. Dette gir økt kroppslig spenning og autonom hyperaktivitet. Overdreven oppmerksomhet for potensielle farer samt en manglende evne til å kontrollere situasjonen får pasienten til å føle seg usikker og hjelpesløs
Funn:
Bortsett fra tegn på angst er det normale kliniske funn
Diagnostikk:
Øvrige undersøkelser er kun aktuelle ved behov for å utelukke annen sykdom
Behandling:
Psykoedukasjon, psykososial støtteterapi, kognitiv terapi, medikamentell behandling
  1. Hoge EA, Ivkovic A, Fricchione GL, Generalized anxiety disorder: diagnosis and treatment. BMJ 2012;345: e7500. www.bmj.com  
  2. McLean CP, Asnaani A, Litz BT, Hofmann SG. Gender Differences in Anxiety Disorders: Prevalence, Course of Illness, Comorbidity and Burden of Illness. J Psychiatr Res 2011; 45: 1027–35. pmid:21439576 PubMed  
  3. Malt U, Andressen OA, Malt EA, Melle I, Årsland D (red). Lærebok i psykiatri. Oslo: Gyldendal akademisk, 2018.
  4. Pansepp J Affective neuroscience. The foundations of human and animal emotions. New York: Oxford University Press, USA, September 3, 2004; ISBN-13: 978-0195178050
  5. Nordahl HM, Borkovec TD, Hagen R, et al. Metacognitive therapy versus cognitive-behavioural therapy in adults with generalised anxiety disorder. BJPsych Open 2018; 4: 393-400. pmid:30294448 PubMed  
  6. Fricchione G. Generalized anxiety disorder. N Engl J Med 2004; 351: 675-82. PubMed  
  7. Simon NM, Blacker D, Korbly NB, et al. Hypothyroidism and hyperthyroidism in anxiety disorders revisited: new data and literature review. J Affect Disord 2002; 69: 209-17. PubMed  
  8. Aarre TF. En mindre medisinsk psykiatri. Oslo: Universitetsforlaget, 2018. tidsskriftet.no  
  9. Nordmo E, Vorren S. Lyrica - norske bivirkningsmeldinger om misbruk. RELIS 2014.
  10. Roszkowska J, Geraci SA. Management of insomnia in the geriatric patient. Am J Med. 2010 Dec;123(12):1087-90. PubMed  
  11. Stein MB, Sareen J. Clinical Practice. Generalized Anxiety Disorder. N Engl J M. 2015; 373:2059-2068. pmid:26580998 PubMed  
  12. Covin R, Ouimet AJ, Seeds PM, et al. A meta-analysis of CBT for pathological worry among clients with GAD. J Anxiety Disord. 2008;22:108-116. PubMed  
  13. Hendriks GJ, Oude Voshaar RC, Keijsers GP, et al. Cognitive-behavioural therapy for late-life anxiety disorders: a systematic review and meta-analysis. Acta Psychiatr Scand. 2008;117:403-411. PubMed  
  14. Kriz S, Solberg B. Kognitiv atferdsterapi. Norsk barne- og ungdomspsykiatrisk forening, veileder i BUP. Publisert 07. juli 2017. legeforeningen.no  
  15. Olthuis JV, Watt MC, Bailey K, et al. Therapist-supported internet cognitive behavioural therapy for anxiety disorders in adults. Cochrane Database Syst Rev. 2016;(3):CD011565. Cochrane (DOI)  
  16. Gosselin P, Ladouceur R, Morin CM, Dugas MJ, Baillargeon L. Benzodiazepine Discontinuation Among Adults With GAD: A Randomized Trial of Cognitive-Behavioral Therapy. J Consult Clin Psychol 2006; 74: 908-19. PubMed  
  17. Baldwin D, Woods R, Lawson R, Taylor D. Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis. BMJ 2011; 342: d1199. BMJ (DOI)  
  18. Slee A, Nazareth I, Bondaronek P et al. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet 2019; S0140-6736: 31793-8. pmid:30712879 PubMed  
  19. Lenze EJ, Rollman BL, Shear K, et al. Escitalopram for older adults with generalized anxiety disorder. JAMA 2009; 301: 295-303. Journal of the American Medical Association  
  20. Frampton J. Pregabalin: A review of its use in adults with generalized anxiety disorder. CNS Drugs 2014; 9: 835-54. pmid:25149863 PubMed  
  21. Starcevic V. Anxiety states: a review of conceptual and treatment issues. Curr Opin Psychiatry 2006; 19: 79-83. PubMed  
  22. Creswell C, Waite P, Cooper PJ, Assessment and management of anxiety disorders in children and adolescents. Arch Dis Child 2014;99: 674-678 PubMed  
  23. Herring MP, O'Connor PJ, Dishman RK. The effect of exercise training on anxiety symptoms among patients: a systematic review. Arch Intern Med. 2010;170:321-331. PubMed  
  24. Larun L, Nordheim LV, Ekeland E, Hagen KB, Heian F. Exercise in prevention and treatment of anxiety and depression among children and young people. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD004691. DOI: 10.1002/14651858.CD004691.pub2. DOI  
  25. Stonerock GL, Hoffman BM, Smith PJ, et al. Exercise as Treatment for Anxiety: Systematic Review and Analysis. Ann Behav Med. 2015;49(4):542-56. PubMed  
  26. Jorm AF, Christensen H, Griffiths KM, Parslow RA, Rodgers B, Blewitt KA. Effectiveness of complementary and self-help treatments for anxiety disorders. Med J Aust 2004; 181: S29-46. PMID: 15462640 PubMed  
  27. Parslow R, Morgan AJ, Allen NB. Effectiveness of complementary and self-help treatments for anxiety in children and adolescents. Med J Aust 2008; 188: 355-9. pmid:18341460 PubMed  
  28. Ravindran AV, da Silva TL. Complementary and alternative therapies as add-on to pharmacotherapy for mood and anxiety disorders: a systematic review. J Affect Disord 2013; 150: 707-19. pmid:23769610 PubMed  
  29. Krisanaprakornkit T, Krisanaprakornkit W, Piyavhatkul N, Laopaiboon M. Meditation therapy for anxiety disorders. Cochrane Database Syst Rev. 2006; 1: CD004998. pmid:16437509 PubMed  
  30. Robinson J, Biley FC, Dolk H. Therapeutic touch for anxiety disorders. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD006240. DOI: 10.1002/14651858.CD006240.pub2. DOI  
  31. Miyasaka LS, Atallah ÁN, Soares B. Passiflora for anxiety disorder. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD004518. DOI: 10.1002/14651858.CD004518.pub2. DOI  
  32. Bruce SE, Yonkers KA, Otto MW, et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry. 2005 Jun;162(6):1179-87. PMID: 15930067. doi.org  
  33. DeMartini J, Patel G, Fancher TL. Generalized Anxiety Disorder. Ann Intern Med. 2019 Apr 2;170(7):ITC49-ITC64. PMID: 30934083. PubMed  
  • Ola Nordviste, psykiater
  • Tor Andre Johannessen, lege og redaktør i NEL

Tidligere fagmedarbeidere

  • Olav Thorsen, spesialist allmennmedisin, Klubbgaten legesenter, Stavanger
  • K Gunnar Götestam, professor, Psykiatrisk institutt, Norges teknisk-naturvitenskapelige universitet, Trondheim